LEADER 02479nam 2200565Ia 450 001 9910876863403321 005 20200520144314.0 010 $a1-118-21026-3 010 $a1-282-38026-5 010 $a9786612380266 010 $a0-470-48540-X 010 $a0-470-48526-4 035 $a(CKB)1000000000822048 035 $a(EBL)469183 035 $a(OCoLC)476315709 035 $a(SSID)ssj0000343663 035 $a(PQKBManifestationID)11252700 035 $a(PQKBTitleCode)TC0000343663 035 $a(PQKBWorkID)10292096 035 $a(PQKB)10064634 035 $a(MiAaPQ)EBC469183 035 $a(PPN)24329526X 035 $a(EXLCZ)991000000000822048 100 $a20081212d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aTherapeutic monoclonal antibodies $efrom the bench to the clinic /$f[edited by] Zhiqiang An 210 $aHoboken, N.J. $cJohn Wiley & Sons$dc2009 215 $a1 online resource (924 p.) 300 $aDescription based upon print version of record. 311 $a0-470-11791-5 320 $aIncludes bibliographical references and index. 327 $aTHERAPEUTIC MONOCLONAL ANTIBODIES; CONTENTS; FOREWORD; PREFACE; CONTRIBUTORS; PART I ANTIBODY BASICS; PART II ANTIBODY SOURCES; PART III IN VITRO DISPLAY TECHNOLOGY; PART IV ANTIBODY ENGINEERING; PART V PHYSIOLOGY AND IN VIVO BIOLOGY; PART VI ANTIBODY CHARACTERIZATION; PART VII ANTIBODY EXPRESSION; PART VIII THERAPEUTIC ANTIBODIES; ABBREVIATIONS; INDEX 330 $a70-chapter authoritative reference that covers therapeutic monoclonal antibody discovery, development, and clinical applications while incorporating principles, experimental data, and methodologies. First book to address the discovery and development of antibody therapeutics in their entirety.Most chapters contain experimental data to illustrate the principles described in them.Authors provide detailed methodologies that readers can take away with them and use in their own laboratories 606 $aMonoclonal antibodies$xTherapeutic use 606 $aImmunotherapy 615 0$aMonoclonal antibodies$xTherapeutic use. 615 0$aImmunotherapy. 676 $a616.07/98 701 $aAn$b Zhiqiang$cDr.$01760682 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910876863403321 996 $aTherapeutic monoclonal antibodies$94199760 997 $aUNINA